Ortho Clinical Diagnostics - a Johnson & Johnson Company.
Global Sites
:
United States (English)
Argentina (Español)
Australia (English)
Belgium (English)
Bolivia (Español)
Brazil (Português)
Canada (English)
Chile (Español)
Colombia (Español)
Costa Rica (Español)
Dominican Republic (Español)
Ecuador (Español)
El Salvador (Español)
France (Français)
Germany (Deutsch)
Guatemala (Español)
Honduras (Español)
Hong Kong SAR (English)
India (English)
Italy (Italiano)
Jamaica (English)
Japan (Japanese)
Mexico (Español)
Netherlands (Nederlands)
New Zealand (English)
Nicaragua (Español)
Panama (Español)
Peru (Español)
Puerto Rico (English)
Scandinavia (English)
Spain (Español)
Trinidad & Tobago (English)
United Kingdom (English)
United States (English)
Uruguay (Español)
Venezuela (Español)
Search:
Search
Our Commitment
Product Information
Customer Toolkit
Technical Documents
Training & Education
Services & Support
Ortho Connect
Patient Materials
Clinical Laboratories
Transfusion Medicine
RhoGAM
Request Product Information
Control Assay Sheets
Instructions For Use Library
MSDS
Clinical Laboratory Tech Docs
Immunohematology Tech Docs
Donor Screening Tech Docs
VITROS® VITAL Topics
Event Calendar
Product Training
e-Connectivity®
Service & Support
Technical Support Center
Field Engineer Service
Predictive Technologies Center
ORTHO PLUS SM Services
Product Training
ValuMetrix Consulting Services®
JJGWC
Register for Updates ›
Media |
Press Releases
Contact Information
|
Johnson & Johnson, Our Parent
|
Press Kit
|
Press Releases
Ortho Clinical Diagnostics Announces Availability of HTLV-I/II Assay
US TRANSFUSION MEDICINE TEAM DEBUTS ORTHO POCKET BLOOD BANKER APP
ORTHO CLINICAL DIAGNOSTICS LAUNCHES “BLOODLINES” BRAND CAMPAIGN INSPIRED BY BLOOD BANKERS
New survey reveals Americans want better access to and understanding of blood test results
Ortho Clinical Diagnostics Announces Availability of Seven Manufacturer-Validated Applications for Thermo Fisher Scientific Immunoassays (July 26, 2011)
Ortho Clinical Diagnostics Launches VITROS
®
4600 Chemistry System for Mid- to High-Volume Laboratories (July 22, 2011)
Announcing ORTHO PLUS
SM
Business Education
Ortho Clinical Diagnostics Receives FDA Clearance for Intact Parathyroid Hormone Assay (Nov. 1, 2010)
Ortho Clinical Diagnostics Enters into Agreement to Develop and Commercialize HTLV-I/II Test (Sept. 13, 2010)
Ortho Clinical Diagnostics Launches FETALSCREEN™ II Fetal Maternal Hemorrhage Screening Test (Oct. 23, 2009)
FDA Approves VITROS® Hepatitis B Surface Antigen Assay for Use on VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnotic Systems (Oct. 26, 2009)
Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test For Use On Random Access, Integrated Laboratory Testing System
Ortho Clinical Diagnostics Launches 24-Hour Remote Monitoring Center (July 21, 2009)
FDA Approves VITROS® Anti-HCV Assay For Use On VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnostic Systems (July 21, 2009)
VITROS® 5600 Integrated System Wins International Product Design Awards
RhoGAM® Brand, Landmark Rh Immune Globulin, Celebrates 40 Years of Saving Babies’ Lives (Feb. 9, 2009)
Two Next Generation Clinical Diagnostics Platforms Now Available in Europe (Jan. 15, 2009)
VITROS® 3600 IMMUNODIAGNOSTIC SYSTEM RECEIVES 510(K) CLEARANCE FROM THE FDA (Dec. 23, 2008)
FDA CLEARS VITROS® 5600 INTEGRATED SYSTEM FOR LABORATORY DIAGNOSTICS (Oct. 24, 2008)
Johnson & Johnson Nordic AB Acquires AMIC (June 18, 2008)
Veridex Announces Agreement To Acquire The Assets of Immunicon Corporation (June 11, 2008)
Ortho Clinical Diagnostics Receives FDA Approval for New HIV Test (March 28, 2008)
Blood Donations in U.S. Testing Positive for Chagas’ Disease (Oct. 20, 2007)